CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-30 | ANDREWS RONALD ASBURY Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2018-08-30 | Redmond Cavan M. Director | Grant or award · Option to Purchase Common Stock | +50,000 | 50,000 | ||
| 2018-08-30 | Arno Andrew Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2018-07-26 | ANNETT WILLIAM President and CEO | Purchase | +3,500 | 3,500 | ||
| 2018-07-26 | ANNETT WILLIAM President and CEO | Purchase · Common stock purchase warrants | +3,500 | 3,500 | ||
| 2018-07-26 | ANDREWS RONALD ASBURY Director | Purchase | +17,482 | 17,482 | ||
| 2018-07-26 | ANDREWS RONALD ASBURY Director | Purchase · Common stock purchase warrants | +17,482 | 17,482 | ||
| 2018-07-26 | Levine Mitchell S Chief Financial Officer | Purchase | +3,495 | 3,495 | ||
| 2018-07-26 | Levine Mitchell S Chief Financial Officer | Purchase · Common stock purchase warrants | +3,495 | 3,495 | ||
| 2018-07-26 | Redmond Cavan M. Director | Purchase | +52,447 | 52,447 | ||
| 2018-07-26 | Redmond Cavan M. Director | Purchase · Common stock purchase warrants | +52,447 | 52,447 | ||
| 2018-07-26 | HESTERBERG LYNDAL K. Sr VP, Research & Development | Purchase | +874 | 874 | ||
| 2018-07-26 | HESTERBERG LYNDAL K. Sr VP, Research & Development | Purchase · Common stock purchase warrants | +874 | 874 | ||
| 2018-07-26 | Last Andrew J. Director | Purchase | +6,993 | 6,993 | ||
| 2018-07-26 | Last Andrew J. Director | Purchase · Common stock purchase warrants | +6,993 | 6,993 | ||
| 2018-07-26 | Arno Andrew Director | Purchase | +52,447 | 52,447 | ||
| 2018-07-26 | Arno Andrew Director | Purchase · Common stock purchase warrants | +52,447 | 52,447 | ||
| 2018-06-13 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2018-06-07 | MECHEM KRISTINE C. VP of Marketing | Grant or award · Option to Purchase Common Stock | +50,000 | 50,000 | ||
| 2018-05-23 | MECHEM KRISTINE C. VP of Marketing | Grant or award · Option to Purchase Common Stock | +125,000 | 125,000 |
Page 19 of 20 · 383 trades